医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

休市中 08-28 16:00:00

921.157

-7.891

-0.85%

最高931.722	最低918.581	成交量7,005万
今开929.484	昨收929.048	日振幅1.41%
总市值0.00	流通市值0.00	总股本0.00
成交额5.16亿	换手率--	流通股本0.00
市净率1.180847	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":921.157,"timestamp":1787904511585,"preClose":929.048,"halted":0,"volume":70046465,"delay":0,"changeRate":-0.008494,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-7.890991,"latestTime":"08-28 16:00:00","open":929.4838,"high":931.72186,"low":918.58057,"amount":515888474,"amplitude":0.014145,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"pbRate":1.180847,"peRate":10.919282,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2663012004","title":"四环医药(00460.HK)委任车雨轩为非执行董事 双轮驱动战略见效中期盈利翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012004?lang=zh_cn&edition=full","pubTime":"2026-08-29 19:13","pubTimestamp":1788002032,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1600","00460","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662309916","title":"瑞丽医美(02135)发布中期业绩 股东应占溢利409.7万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662309916","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662309916?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:17","pubTimestamp":1787926662,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞丽医美(02135)发布截至2026年6月30日止6个月中期业绩，集团收益人民币1.15亿元，同比增长35.67%;股东应占溢利409.7万元，同比扭亏为盈;每股盈利0.74分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1209","BK1593","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662064042","title":"复星医药(02196)授出合计72.51万份A股期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2662064042","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662064042?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:57","pubTimestamp":1787914660,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年8月28日，董事会决议根据2025年A股期权计划于同日向100名A股期权激励对象授予合计72.51万份A股期权(对应72.51万股公司A股，约占截至本公告日期公司已发行股份总数的0.0272%)。根据2025年A股期权计划，A股期权预留授予的行权价格为人民币27.93元╱股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03188","BK0175","02846","03130","BK0096","82846","02827","02196","BK1593","BK0028","07233","83130","BK0196","BK0239","BK0012","BK0060","BK1515","BK1147","BK0188","159982","BK0183","399300","BK0187","600196","BK1191","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662651550","title":"昊海生物科技(06826.HK)8月28日斥资105.3万港元回购6.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662651550","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662651550?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:36","pubTimestamp":1787909818,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662197065","title":"昊海生物科技(06826)8月28日斥资105.3万港元回购6.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662197065","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662197065?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:36","pubTimestamp":1787909818,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年8月28日斥资105.3万港元回购6.38万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662094216","title":"【生物医药小白投研】第五篇：读懂BD的价值逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662094216","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662094216?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:50","pubTimestamp":1787907000,"startTime":"0","endTime":"0","summary":"在生物医药二级市场，BD是出现频率最高、对股价影响较为直接的核心词汇之一。但在A股、港股创新药赛道，能够对股价形成重大催化的BD交易，大多特指药物全球权益授权交易。首付款是海外顶级药企对药物当下真实价值的投票，是BD含金量的核心判断依据。BD出海让一款药物同时覆盖国内+全球市场，估值逻辑彻底升级。例如科伦博泰、信达生物等，持续兑现出海BD，研发实力全球认可。NO.6小白必须警惕以下BD误区误区一：BD落地股价必涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650514013&idx=2&sn=a94c778f97f0744682cc347b39421f20&chksm=f382c39a6e71d39b1967e69c7fe65ec399f4658e5a18b93c3b2c95e183487c32d8cdc7dd65d9&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU0828237510.HKD","LU0244354667.USD","LU1188198961.HKD","BK1589","ONC","LU1770034418.SGD","LU2242644610.SGD","LU2488822045.USD","LU0326950275.SGD","LU0588546209.SGD","01801","LU2097828631.EUR","LU2328871848.SGD","LU0455707207.USD","BK1593","LU1969619763.USD","01530","688235","LU0463099449.HKD","LU1251922891.USD","LU0228659784.USD","BK1583","KURE","LU2097828805.USD","HK0000165453.HKD","BK1161","LU2097828474.EUR","LU0307460666.USD","BK1500","LU0196878994.USD","LU1303224171.USD","LU2097828714.EUR","LU0502904849.HKD","LU1719994722.HKD","BK1588","06160","LU2097828557.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704034","title":"现代牙科：上半年纯利约3.78亿港元，同比增30.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704034","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662704034?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:47","pubTimestamp":1787831220,"startTime":"0","endTime":"0","summary":"8月27日，现代牙科（03600）发布截至2026年6月30日止六个月的业绩公告。公告显示，公司收益约为20.32亿港元，较2025年同期的18.35亿港元增加约10.8%。收益增长主要受全球牙科行业加快数字化采纳的推动，尤其是在欧洲和澳洲市场。同时，中国内地市场趋于稳定，运营转变也为增长贡献了力量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608273856703370.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608273856703370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","03600","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706036","title":"现代牙科(03600)发布中期业绩，股东应占溢利3.74亿港元 同比增加31.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662706036?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:53","pubTimestamp":1787827988,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)发布截至2026年6月30日止6个月中期业绩，该集团取得收益20.32亿港元，同比增加10.8%;本公司拥有人应占溢利3.74亿港元，同比增加31.23%;每股基本盈利40.07港仙;中期股息每股普通股 14.0港仙。公告称，收益增长主要由于集团持续的自然增长-受全球牙科行业加快采纳数码化所推动(特别是欧洲及澳洲)-连同中国内地市场趋向稳定及营运上的转变。此扩张部分被北美的收益减少所抵销，其因宏观经济环境疲软而影响高价值的非必需医疗项目，以及管理层的策略决策(即精简亏损的牙科服务组织(DSO)账户)以优化客户组合并保护利润。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","03600","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662591706","title":"四环医药(00460.HK)8月27日耗资811.1万港元回购1000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662591706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662591706?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:39","pubTimestamp":1787827197,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1600","BK1515","BK1593","BK1191","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770822","title":"复星医药(02196)8月27日斥资358.7万港元回购21.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770822","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662770822?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:36","pubTimestamp":1787823362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年8月27日斥资358.7万港元回购21.7万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0175","BK0012","BK0028","BK0239","BK0196","BK1593","BK1191","BK1515","BK0183","600196","02196","BK0188","BK0187","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662777796","title":"昊海生物科技(06826.HK)8月27日斥资24.78万港元回购1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662777796","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662777796?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:31","pubTimestamp":1787823099,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662079818","title":"复星医药半年报：创新药收入飙涨13.8%，全球化棋局落子三大洲","url":"https://stock-news.laohu8.com/highlight/detail?id=2662079818","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662079818?lang=zh_cn&edition=full","pubTime":"2026-08-26 14:51","pubTimestamp":1787727060,"startTime":"0","endTime":"0","summary":"复星医药董事长陈玉卿表示：“面对行业变局，我们以战略聚焦应对外部不确定性，坚定践行创新与国际化，聚焦肿瘤、免疫炎症、神经退行性疾病核心领域，依托全球化布局与BD双向赋能，锻造商业化能力。”创新密集兑现：7个新品、20项适应症集中获批2026年上半年，复星医药研发总投入达32.47亿元，同比增长25.66%，其中创新药研发占比高达81.61%，资金精准投向HLX43、HLX22、GR1803等重磅管线及核药、小核酸等前沿技术平台。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-26/doc-iniprqcv6131571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","IBBQ","MEDX","06978","BK0183","BK0096","600196","BK1161","BK1515","BK1574","BK0060","BK1191","BK0196","BK0239","02196","BK1593","159992","BK0188","BK0012","LNGR","BK0175","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760937","title":"四环医药：缪瑰丽辞任执行董事 宋晓弥接任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760937","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662760937?lang=zh_cn&edition=full","pubTime":"2026-08-26 13:51","pubTimestamp":1787723460,"startTime":"0","endTime":"0","summary":"8月26日，四环医药（00460）发布公告，公司执行董事、副行政总裁及首席财务官缪瑰丽因专注个人事业发展辞任。同时，公司委任车雨轩为非执行董事及董事会风险管理委员会委员，委任宋晓弥为首席财务官。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608263854445757.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608263854445757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662676239","title":"四环医药(00460)发布中期业绩 股东应占溢利2.25亿元 同比增加119% 持续锚定“医美+创新药”双轮驱动中长期发展战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2662676239","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662676239?lang=zh_cn&edition=full","pubTime":"2026-08-26 12:31","pubTimestamp":1787718705,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布截至2026年6月30日止6个月业绩，该集团期内取得总收益11.61亿元，同比增加1.3%;公司拥有人应占溢利2.25亿元，同比增加119%;每股基本盈利2.49分。公告称，收益的变化，主要来自医美及创新药业务驱动。期内，医美业务的收益约为人民币6.93亿元，同比上升约18.5%。医美业务保持稳健发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00460","BK1515","BK1191","BK1600","LNGR","BK1593","06978","159992","MEDX","BK1574","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662764288","title":"四环医药：上半年拥有人应占溢利约2.2亿元 同比上升119%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662764288","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662764288?lang=zh_cn&edition=full","pubTime":"2026-08-26 12:11","pubTimestamp":1787717487,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101194677","title":"四环医药人事变动：苗贵利辞任执行董事、副总经理及首席财务官，8月26日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1101194677","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101194677?lang=zh_cn&edition=full","pubTime":"2026-08-26 12:03","pubTimestamp":1787717017,"startTime":"0","endTime":"0","summary":"四环医药近日发布公告，披露了一项重要的人事调整。公司宣布，苗贵利先生已正式提出辞呈，将卸任其在公司担任的多项关键职务，包括执行董事、副总经理以及首席财务官。据悉，这一变动将自2026年8月26日起正式生效。苗贵利先生的离职涉及多个核心管理岗位，其辞任范围之广，在公司治理层面引起了广泛关注。截至目前，四环医药尚未就接任人选或过渡计划发布进一步说明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","00460","BK1600","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662591307","title":"股市必读：复星医药新发布《复星医药第十届董事会第三十六会议（定期会议）决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662591307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662591307?lang=zh_cn&edition=full","pubTime":"2026-08-26 01:25","pubTimestamp":1787678711,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，复星医药报收于23.02元，上涨1.01%，换手率1.09%，成交量23.05万手，成交额5.27亿元。当日关注点交易信息汇总：8月25日主力资金净流入3383.79万元，占总成交额6.42%。公司公告汇总：复星医药第十届董事会第三十六次会议审议通过2026年半年度报告及中长期战略规划等五项议案，全部获全票通过。所有议案均获通过，无反对或弃权票。相关报告已在上证所网站披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600003876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0196","BK0239","BK0060","BK0188","600196","BK0012","BK1515","BK0028","02196","BK1191","BK0175","BK0183","BK1593","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973187","title":"【投融资动态】托尔时代天使轮融资，融资额近亿人民币，投资方为中科创星、元禾原点等","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662973187?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:33","pubTimestamp":1787657584,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于8月24日公布的信息整理，托尔时代科技（成都）有限公司天使轮融资，融资额近亿人民币，参与投资的机构包括中科创星，元禾原点。托尔时代专注于NBI系统的全栈研发与交付，并掌握了三条主要技术路线：弧放电正离子源中性束、射频正离子源中性束以及射频负离子源中性束。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500042133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1587","MUCmain","BK1593","CYB","06699","UCmain","BK1100","CNHmain","BK1583","MCNHmain","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780752","title":"昊海生物科技(06826.HK)8月25日耗资19.62万港元回购1.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780752","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662780752?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:27","pubTimestamp":1787650027,"startTime":"0","endTime":"0","summary":"格隆汇8月25日丨昊海生物科技(06826.HK)发布公告，2026年8月25日耗资19.62万港元回购1.2万股，回购价格每股16.3-16.49港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32346519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222503","title":"昊海生物科技(06826)8月24日斥资393.9万港元回购24.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222503","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661222503?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:25","pubTimestamp":1787563513,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年8月24日斥资393.9万港元回购24.96万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}